Mon, May 18, 2026

Global Edition

VENDETANEWS

WorldPoliticsTechBusinessSports

Mon, May 18, 2026

Health News

FDA Grants Early Access to Experimental Pancreatic Cancer Drug

May 14, 2026

FDA Grants Early Access to Experimental Pancreatic Cancer Drug

The FDA has approved early access to daraxonrasib, a promising drug for metastatic pancreatic cancer. Patients with limited treatment options may now qualify for the experimental therapy under a special program, offering new hope in a field with grim survival rates.